Effect of HAART on SEN Virus Infected HIV Positive Patients
Pirovano, S.; Malacarne, F.; Ballerini, C.; Stellini, R.; Palvarini, L.; Albertini, A.; Imberti, L.
Clinical Laboratory 49(3-4): 123-127
2003
ISSN/ISBN: 1433-6510 PMID: 12705693 Document Number: 8764
Since it has been demonstrated that concomitant infections could influence the outcome of antiviral treatment, we investigated whether the presence of SENV infection may interfere with highly active antiretroviral therapy (HAART) in HIV+ coinfected patients. In spite of persistent fluctuations in SENV-A positivity we could not find any correlation between SENV-DNA and the immunological and virologic parameters found in the patients, suggesting SENV has no apparent clinical relevance during highly active antiretroviral therapy.
Document emailed within 1 workday
Related Documents
Pastori, C.; Barassi, C.; Lillo, F.; Longhi, R.; Capiluppi, B.; Nozza, S.; Galli, A.; Uberti-Foppa, C.; Lazzarin, A.; Tambussi, G.; Lopalco, L. 2002: The effect of HAART on humoral immune response in primary HIV-1 infected patients Journal of Biological Regulators and Homeostatic Agents 16(1): 9-17Sharma, M.; Legesse, H. 2016: Parametric Modeling of Survival Data Based on Human Immune Virus (HIV) Infected Adult Patients under Highly Active Antiretroviral Therapy (HAART): a Case of Zewditu Referral Hospital, Addis Ababa (AA), Ethiopia International Journal of Statistics in Medical Research 5(4): 240-247
Pessoa, S.D.; Miyamoto, M.; Ono, E.; Gouvêa, A.íd.F.T.B.; de Moraes-Pinto, M.I.; Succi, R.C.M. 2010: Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART Vaccine 28(6): 1606-1612
Varella, R.B.ão.; Ferreira, S.B.ía.; Castro, M.ár.B.d.; Tavares, M.D.; Zalis, M.G. 2008: Prevalence of resistance-associated mutations in human immunodeficiency virus type 1-positive individuals failing HAART in Rio de Janeiro, Brazil Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(5): 380-384
Laufer, N.L.; Quarleri, J.F.; Bouzas, M.B.; Perez, H.M.; Salomon, H.; Cahn, P.E. 2007: HBV and HCV co-infections in HIV positive patients in the "HAART era": new challenges Medicina 67(1): 82-91
De Giorgio, F.; Abbate, A.; Capelli, A.; Arena, V. 2005: Spontaneous rupture of coronary artery in human immunodeficiency virus-positive patient treated with highly active anti-retroviral therapy (HAART) American Journal of Forensic Medicine and Pathology 26(2): 197
Nyesigire Ruhinda, E.; Bajunirwe, F.; Kiwanuka, J. 2012: Anaemia in HIV-infected children: severity, types and effect on response to HAART Bmc Pediatrics 12: 170
Kannangai, R.; Ramalingam, S.; Vijayakumar, T.S.; Vincent, A.A.; Abraham, O.C.; Subramanian, S.; Rupali, P.; Mathai, D.; Jesudason, M.V.; Sridharan, G. 2003: The immunological and virological response in human immunodeficiency virus type-1 (HIV-1) infected Indian individuals on HAART therapy: a one-year follow up study Indian Journal of Medical Microbiology 21(4): 274-276
Punyaratabandhu, P.; Prasithsirikul, W.; Jirachanakul, P. 2012: Skin manifestation of Thai HIV infected patients in HAART era Journal of the Medical Association of Thailand 95(4): 497-504
Julius, H.; Basu, D.; Ricci, E.; Wing, J.; Basu, J.K.; Pocaterra, D.; Bonfanti, P. 2011: The burden of metabolic diseases amongst HIV positive patients on HAART attending the Johannesburg Hospital Current HIV Research 9(4): 247-252
Julius, H.; Basu, D.; Ricci, E.; Wing, J.; Basu, J.K.; Pocaterra, D.; Bonfanti, P. 2011: The burden of metabolic diseases amongst HIV positive patients on HAART attending the Johannesburg Hospital Current HIV Research 9(4): 247-252
Palacios, E.; Franke, M.; Muñoz, M.; Hurtado, R.; Dallman, R.; Chalco, K.; Guerra, D.; Mestanza, L.; Llaro, K.; Bonilla, C.; Sebastian, J.; Bayona, J.; Lygizos, M.; Lyzigos, M.; Anger, H.; Shin, S. 2012: HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 16(3): 348-354
Chandrasekhar, A.; Gupta, A. 2011: Nutrition and disease progression pre-highly active antiretroviral therapy (HAART) and post-HAART: can good nutrition delay time to HAART and affect response to HAART? American Journal of Clinical Nutrition 94(6): 1703s-1715s
Bedingfield, N.; Kipp, W.; Kaler, A.; Rubaale, T. 2014: Revelations of HIV-infected patients treated with highly active antiretroviral therapy (HAART) in rural Uganda Aids Care 26(1): 75-78
Kalikar, M.V.; Thawani, V.R.; Varadpande, U.K.; Sontakke, S.D.; Singh, R.P.; Khiyani, R.K. 2008: Immunomodulatory effect of Tinospora cordifolia extract in human immuno-deficiency virus positive patients Indian Journal of Pharmacology 40(3): 107-110
Kiertiburanakul, S.; Sungkanuparph, S.; Rattanasiri, S.; Manosuthi, W.; Vibhagool, A.; Thakkinstian, A. 2006: Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3 Journal of the Medical Association of Thailand 89(9): 1381-1387
Breuckmann, F.; Neumann, T.; Kondratieva, J.; Wieneke, H.; Ross, B.; Nassenstein, K.; Barkhausen, J.; Kreuter, A.; Brockmeyer, N.; Erbel, R. 2005: Dilated cardiomyopathy in two adult human immunodeficiency positive (HIV+) patients possibly related to highly active antiretroviral therapy (HAART) European Journal of Medical Research 10(9): 395-399
Akinbo, F.O.; Omoregie, R. 2012: Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria Journal of Research in Health Sciences 12(1): 15-18
Menezes, A.éi.M.; Torelly, J.; Real, L.úc.; Bay, M.ôn.; Poeta, J.; Sprinz, E. 2011: Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in Brazil Plos one 6(10): E26042
Jallow, S.; Alabi, A.; Sarge-Njie, R.; Peterson, K.; Whittle, H.; Corrah, T.; Jaye, A.; Cotten, M.; Vanham, G.; McConkey, S.J.; Rowland-Jones, S.; Janssens, W. 2009: Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants Journal of Clinical Microbiology 47(7): 2200-2208